Shares of Quest Diagnostics ( DGX) sank 3% Thursday after the lab specialist guided lower for 2007.

The diagnostic test outfit earned $151 million, or 77 cents a share, in the fourth quarter, vs. $149 million, or 73 cents a share, in the year-ago period. Analysts surveyed by Thomson First Call expected Quest to earn 74 cents a share.

Revenue grew 8.5% to $1.55 billion, thanks in part to Quest's acquisition of LabOne in November 2005 and Focus Diagnostics in July of last year. Analysts expected revenue of $1.57 billion.

For 2007, the company expects earnings of between $2.70 and $3 a share on $6 billion to $6.2 billion in revenue. Analysts were expecting earnings of $3.21 a share on sales of $6.4 billion for the year.

Quest's 2007 estimates reflect reductions related to the anticipated impact of contract changes, the company said in a press release Thursday. Last October, huge insurer UnitedHealth ( UNH) dropped Quest in favor of rival LabCorp ( LH), saying LabCorp was cheaper.

Shares fell $1.58 to $49.48.

More from Stocks

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Complying With GDPR Could Be Costly for Facebook, Google and Other Tech Giants

Complying With GDPR Could Be Costly for Facebook, Google and Other Tech Giants

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

North Korea, Apple, GPDR and Gap - 5 Things You Must Know

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation